Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy 2-month-old infants (42 to 98 days)~* Available for the entire study period (14 months)~Exclusion Criteria:~* Previous vaccination with pneumococcal, diphtheria, tetanus, pertussis, polio, or Hib vaccines~* A previous anaphylactic reaction to any vaccine or vaccine-related component.

- Gender: ALL
- Minimum Age: 42 Days
- Maximum Age: 98 Days
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 13vPnC
- 2 (Type: ACTIVE_COMPARATOR): 7vPnC

Based on this trial design, predict the completion outcome and termination type (if applicable).